COVID-19 vaccine development pipeline gears up

[gracielle]

China temporarily blocks entry to WHO team studying COVID's origins

Chinese Authorities said visas have not yet been approved for the World Health Organization delegation visiting Wuhan.

china-underground.com

Reuters | Breaking International News & Views

Find latest news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.

uk.reuters.com

https://www.ambito.com/mundo/china/como-empezo-sigue-negociando-la-oms-investigar-el-origen-del-coronavirus-

 

[gracielle]

COVID-19: científicos de Estados Unidos estiman que la memoria inmune dura al menos ocho meses

Expertos de la Universidad de California publicaron un estudio en el que ayudaron a determinar el tiempo que dura la inmunidad contra el coronavirus en el cuerpo, con el fin de mejorar los diagnósticos y las campañas sanitarias

www.infobae.com

AAAS

science.sciencemag.org

 

[gracielle]

El Gobierno prepara otro vuelo a Moscú la semana próxima para traer el segundo cargamento de vacunas

La fecha que se evalúa por estas horas es el 14 de enero. Traerá la segunda dosis de las 300 mil vacunas que llegaron el 24 de diciembre

www.infobae.com

7 December 2021
The government is preparing another flight to Moscow next week to bring the second shipment of vaccines, the date being evaluated at this time is January 14. It will bring the second dose of the 300 thousand vaccines that arrived on December 24.

Although everything indicated that the next trips would be to South Korea or India, where the Russian vaccine is produced for the Argentine market, the Government launched a travel plan to return to the Russian capital. The date that is evaluated is January 14 at 8:35 in the morning, to return to Buenos Aires on the 15th around midnight. But everything can change with the market for vaccines. In fact, the first trip also suffered modifications due to administrative issues that were resolved at the last minute....

 

[gracielle]

COVID vaccines: Where do they come from? Where will they go? – DW – 01/05/2021

The great vaccination race is underway around the globe. Several drugmakers are racing to deliver on what they hope will be life-saving drugs. DW breaks down what's going where.

www.dw.com

 

[gracielle]

Coronavirus: vacuna de Sinovac arroja efectividad del 78% en Brasil

Coronavirus: vacuna de Sinovac arroja efectividad del 78% en Brasil

www.lanacion.com.ar

7 January 2021
Coronavirus: Sinovac vaccine shows 78% effectiveness in Brazil
SAN PABLO.- A coronavirus vaccine developed by Sinovac Biotech was 78% effective in late-phase clinical trials in Brazil, São Paulo state authorities said Thursday, in a step forward for the efforts of Chinese pharmaceutical companies to match the results of its western peers.

Brazil and Indonesia, which have the highest number of coronavirus cases in Latin America and Southeast Asia respectively, are preparing to start using Sinovac's CoronaVac vaccine this month. Sinovac also has supply agreements with Turkey, Chile, Singapore, Ukraine and Thailand....

 

[gracielle]

"Nada indica que las vacunas no sirvan para las nuevas cepas del coronavirus", afirma el virólogo británico Daniel Bausch

El experto asegura que por el momento las mutaciones no son tan grandes. Y prevé que recién se volverá a cierta "normalidad" en 6 meses.

www.clarin.com

7 January 2021
Interview:
"Nothing indicates that vaccines are not suitable for new strains of the coronavirus," says British virologist Daniel Bausch
The expert assures that at the moment the mutations are not so great. And he foresees that it will only return to a certain "normality" in 6 months.

The British Kent and South African variants of Covid-19 are rapidly advancing in 40 and 22 countries respectively. The definitive answer to these mutations will be in the cultures and in the laboratory studies, which have not been completed. So far "there is no evidence that forces to alter the composition of existing vaccines." But we will have to wait "at least 6 to 8 months to regain a certain normality", which will not be like before.

This is the diagnosis of Professor Daniel Bausch, British virologist, specialist in tropical medicine, director of the Rapid Support Team for British Public Health, researcher at the London School of Hygiene and Tropical Medicine and a long and respected track record of virus research in Sub-Saharan Africa, in Latin America and Asia on Ebola, Lassa, hantavirus and SARS coronavirus. One of the most respected and authoritative voices in the world to analyze Covid and its Kentish and South African variants...

 

[gracielle]

Vacunas contra el coronavirus: El Gobierno confirmó la llegada de la segunda tanda de la Sputnik V, mientras negocia con China y Brasil | El vuelo en busca del cargamento partirá la próxima semana hacia Rusia

Además de anunciar el arribo de las nuevas dosis de la vacuna de origen ruso, el Gobierno avanza en las gestiones para concretar la compra de un millón de vacunas Sinopharm, que comenzarían a llegar desde China en las próximas semanas. También hay nego...

www.pagina12.com.ar

7 January 2021
Vaccines against the coronavirus: The Government confirmed the arrival of the second round of Sputnik V, while negotiating with China and Brazil
In addition to announcing the arrival of new doses of the vaccine of Russian origin, the Government is making progress in the negotiations to finalize the purchase of one million Sinopharm vaccines, which would begin to arrive from China in the coming weeks. There are also open negotiations with Brazil to acquire the Coronavac vaccine, from the Chinese laboratory Sinovac and developed by the Butantan Institute....
....The minister added that at the end of March "a very important quantity of the vaccine manufactured here" will be added to these doses from Russia, in reference to the one developed by the pharmaceutical company AstraZeneca. He also gave an account of the negotiations for the Sinopharm vaccine: "Today we are negotiating with China one million doses for January," he detailed. In addition, he assured that "negotiations continue" with other suppliers and reiterated that "a new proposal was made to Pfizer to see if they accept."...

 

[gracielle]

Avanza una nueva vacuna contra el COVID-19 con nanopartículas que no necesitará refrigeración y será de una sola dosis

Se desarrolla en la Universidad de Stanford, en Estados Unidos. Ya ha sido probada con ratones y pronto comenzarán las pruebas en humanos. Apunta especialmente a los países en desarrollo que tienen dificultades logísticas para distrbuir las vacunas ya aprobadas

www.infobae.com

7 January 2021
A new vaccine against COVID-19 with nanoparticles that will not need refrigeration and will be a single dose is being developed at Stanford University, in the United States. It has already been tested in mice and human trials will begin soon. It is especially aimed at developing countries that have logistical difficulties in distributing already approved vaccines....University researchers have said that this development was based on their experience in studies of vaccines against HIV, Ebola and pandemic influenza, which were in development before the coronavirus outbreak spread around the world.

Although SARS-CoV-2 is outside the laboratory's specific area of specialization, since the declaration of the pandemic, Stanford researchers have been developing a promising vaccine candidate against this virus, which already has important advances. “Our goal is to make a single-shot vaccine that does not require a cold chain for storage or transportation. If we get it right, it should also be cheap, ”said Peter S. Kim, who is a professor of biochemistry at Virginia and DK Ludwig. "The target population for our vaccine is low- and middle-income countries."....

 

[gracielle]

Vacuna rusa versus vacuna china: en qué se diferencian y cuáles son sus efectos secundarios

El Gobierno confirmó la llegada de un millón de dosis de la vacuna Sinopharm. La Fundación Huésped había comenzado un ensayo fase tres de la vacuna en septiembre. Cómo funciona.

www.infotechnology.com

7 January 2021
Russian vaccine vs Chinese vaccine: how they differ and what are their side effects
The Government confirmed the arrival of one million doses of the Sinopharm vaccine. The Fundacion Huesped had begun a phase three trial of the vaccine in September. How does it work....

In an exchange of letters, President Alberto Fernández wrote to Xi Jinping, the Chinese president, that "Argentina is prepared to strengthen cooperation with China in various sectors, including vaccines." Beijing responded positively and they will cooperate in the research, development and application of vaccines against SARS-CoV-2. In total, they hope to buy between 15 and 30 million doses of Sinopharm vaccines.

At the end of August, the Ministry of Health agreed with China to start a clinical trial of Sinopharm. In September, the infectious disease specialist Pedro Cahn, director of Fundacion Huesped, announced the beginning of Phase 3. Three thousand persons were enrolled in the study and it will last 12 months. The tests are financed by the Argentine laboratory Elea....
HOW THE SPUTNIK V AND SINOPHARM VACCINES ARE DIFFERENT....

 

[gracielle]

Vacuna Sputnik V: cuánto tarda la inmunidad contra el coronavirus después de la primera dosis

El efecto del antídoto en el cuerpo no es instantáneo, sino que requiere de un proceso que puede demorar entre 14 días y un mes. Qué sucede si se pospone la segunda inyección.

www.perfil.com

7 January 2021
Vaccine Sputnik V: how long does it take to reach immunity against the covid after receiving the first dose. The effect of the antidote in the body is not instantly. It requires a process which could have a delay between 14 days and a month. What will happen if the second inyeccion is postponed....

Vacunas contra el coronavirus: ¿alcanza una dosis para obtener inmunidad?

La vacunación ya comenzó en distintos países del mundo y es un paso clave para detener el avance del coronavirus a nivel global

www.iprofesional.com